Tech Transfer Tidbits | GenomeWeb

Tech Transfer Tidbits

Premium

JWCI, NIH, CHLA License IP to CerRx Related to Using Vitamin A Formulation as Cancer Treatment

The John Wayne Cancer Institute at Saint John's Health Center, the National Institutes of Health, and Children's Hospital Los Angeles have granted Texas biotech CerRx worldwide exclusive rights to intellectual property and know-how related to a formulation of vitamin A to treat cancer, JWCI said last week.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.